The latest closing stock price for Innate Pharma S.A as of January 31, 2025 is 1.83.
An investor who bought $1,000 worth of Innate Pharma S.A stock at the IPO in 2019 would have $-702 today, roughly -1 times their original investment - a -21.50% compound annual growth rate over 5 years.
The all-time high Innate Pharma S.A stock closing price was 8.20 on May 11, 2020.
The Innate Pharma S.A 52-week high stock price is 3.51, which is 91.8% above the current share price.
The Innate Pharma S.A 52-week low stock price is 1.29, which is 29.5% below the current share price.
The average Innate Pharma S.A stock price for the last 52 weeks is 2.22.
An investor who bought $1,000 worth of Innate Pharma S.A stock at the IPO in 2019 would have $-702 today, roughly -1 times their original investment - a -21.50% compound annual growth rate over 5 years.
The all-time high Innate Pharma S.A stock closing price was 8.20 on May 11, 2020.
The Innate Pharma S.A 52-week high stock price is 3.51, which is 91.8% above the current share price.
The Innate Pharma S.A 52-week low stock price is 1.29, which is 29.5% below the current share price.
The average Innate Pharma S.A stock price for the last 52 weeks is 2.22.